Onclive articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Tue, 22 Jul 2014 11:26:06 EDT 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Bevacizumab Receives Priority Review in Ovarian Cancer]]>http://www.onclive.com/web-exclusives/Bevacizumab-Receives-Priority-Review-in-Ovarian-CancerOnclive articlesusTue, 22 Jul 2014 10:45:01 EDTOnclive<![CDATA[Amid Calls for Standardization, Oncology Medical Homes Grow]]>http://www.onclive.com/publications/oncology-business-news/2014/June-2013/Amid-Calls-for-Standardization-Oncology-Medical-Homes-GrowOnclive articlesusTue, 22 Jul 2014 09:43:51 EDTOnclive<![CDATA[Immunotherapy Combination Receives Breakthrough Designation for Pancreatic Cancer]]>http://www.onclive.com/web-exclusives/Immunotherapy-Combination-Receives-Breakthrough-Designation-for-Pancreatic-CancerOnclive articlesusMon, 21 Jul 2014 16:46:15 EDTOnclive<![CDATA[ASCO 2014: Gearing Up for More Changes]]>http://www.onclive.com/publications/obtn/2014/July-2014/ASCO-2014-Gearing-Up-for-More-ChangesOnclive articlesusMon, 21 Jul 2014 09:37:49 EDTOnclive<![CDATA[Dr. Goldstein on Mechanisms of Resistance to Endocrine Therapy]]>http://www.onclive.com/conference-coverage/ibc-2014/Dr-Goldstein-on-Mechanisms-of-Resistance-to-Endocrine-TherapyOnclive articlesusSat, 19 Jul 2014 16:39:26 EDTOnclive<![CDATA[Dr. Tripathy on Decision-Making for Sequencing Therapies for HER2-Positive MBC]]>http://www.onclive.com/conference-coverage/ibc-2014/Dr-Tripathy-on-Decision-Making-for-Sequencing-Therapies-for-HER2-Positive-MBCOnclive articlesusFri, 18 Jul 2014 19:05:33 EDTOnclive<![CDATA[IDH2 Inhibitor Shows Promise in AML]]>http://www.onclive.com/publications/obtn/2014/June-2014/IDH2-Inhibitor-Shows-Promise-in-AMLOnclive articlesusFri, 18 Jul 2014 16:02:20 EDTOnclive<![CDATA[Dabrafenib/Trametinib Extends OS Versus Vemurafenib in Phase III Melanoma Trial]]>http://www.onclive.com/web-exclusives/DabrafenibTrametinib-Extends-OS-Versus-Vemurafenib-in-Phase-III-Melanoma-TrialOnclive articlesusFri, 18 Jul 2014 13:41:30 EDTOnclive<![CDATA[Immunotherapy Branches Out]]>http://www.onclive.com/publications/Oncology-live/2014/July-2014/Immunotherapy-Branches-OutOnclive articlesusFri, 18 Jul 2014 09:03:13 EDTOnclive<![CDATA[Dr. O’Shaughnessy on Breast Cancer Subtype-Specific Cytotoxic Agents]]>http://www.onclive.com/conference-coverage/ibc-2014/Dr-OShaughnessy-on-Breast-Cancer-Subtype-Specific-Cytotoxic-AgentsOnclive articlesusThu, 17 Jul 2014 17:53:27 EDTOnclive